Despite Considerable Partnering, Ablynx Hopes To Take TTP Nanobody Drug To Market Itself
This article was originally published in The Pink Sheet Daily
Executive Summary
Best known for cash-generating tie-ups with the likes of Pfizer and Novartis, the Belgian biotech plans to market its own niche products.